Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 18,325 |
|
|||||
| News | - | ||||||
| Day High | 1.84 | Low High |
|||||
| Day Low | 1.66 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sonnet BioTherapeutics Holdings Inc | SONN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.085 | 5.01% | 1.78 | 17:17:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.72 | 1.66 | 1.84 | 1.78 | 1.695 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 159 | 18,325 | $ 1.78 | $ 32,587 | - | 1.08 - 26.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:32:02 | 20 | $ 1.79 | USD |
Sonnet BioTherapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.46M | 3.07M | - | 148k | -18.83M | -6.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sonnet BioTherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SONN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.80 | 1.91 | 1.65 | 1.73 | 19,089 | -0.02 | -1.11% |
| 1 Month | 2.08 | 2.17 | 1.65 | 1.91 | 28,013 | -0.30 | -14.42% |
| 3 Months | 1.50 | 2.3399 | 1.31 | 1.98 | 109,560 | 0.28 | 18.67% |
| 6 Months | 2.35 | 2.35 | 1.08 | 1.75 | 90,022 | -0.57 | -24.26% |
| 1 Year | 5.4978 | 26.40 | 1.08 | 10.11 | 1,289,099 | -3.72 | -67.62% |
| 3 Years | 625.24 | 840.84 | 1.08 | 150.12 | 2,926,092 | -623.46 | -99.72% |
| 5 Years | 1,915.76 | 4,989.60 | 1.08 | 329.84 | 2,618,631 | -1,913.98 | -99.91% |
Sonnet BioTherapeutics Description
| Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. |
